Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Zavegepant. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL known ✓ | Q16602 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CALCA | P06881 | 16/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zavegepant SCHEMBL29360253 | 1.00 | CALCRL (1.00) | CALCRLCYP3A4CALCA | |
| Zavegepant SCHEMBL107428 | 1.00 | CALCRL (1.00) | CALCRLCYP3A4CALCA | |
| Zavegepant SCHEMBL29918913 | 1.00 | CALCRL (1.00) | CALCRLCYP3A4CALCA | |
| Zavegepant SCHEMBL142472 | 1.00 | CALCRL (1.00) | CALCRLCYP3A4CALCA | |
| Zavegepant SCHEMBL29182146 | 0.99 | CALCRL (0.99) | CALCRLCYP3A4CALCA | |
| Zavegepant SCHEMBL29918668 | 0.99 | CALCRL (0.99) | CALCRLCYP3A4CALCA | |
| SCHEMBL30763651 | 0.97 | CALCRL (0.95) | CALCRLCYP3A4CALCA | |
| SCHEMBL29161729 | 0.97 | CALCRL (0.95) | CALCRLCYP3A4CALCA | |
| SCHEMBL29161731 | 0.97 | CALCRL (0.95) | CALCRLCYP3A4CALCA | |
| SCHEMBL178848 | 0.93 | CALCRL (0.88) | CALCRLCYP3A4CALCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3863629-A1 | PRODRUGS OF CGRP ANTAGONISTS | Biohaven Pharmaceutical Holding Company Ltd. (US) | 2021-08-18 | — | — | EP | disclosed |